These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7060546)

  • 21. Immunotoxicology: An overview.
    Dean JH
    Toxicol In Vitro; 1994 Oct; 8(5):933-7. PubMed ID: 20693049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo assays for immunotoxicity studies.
    Speirs RS
    Prog Clin Biol Res; 1984; 161():159-69. PubMed ID: 6483883
    [No Abstract]   [Full Text] [Related]  

  • 23. Justification for routine screening of pharmaceutical products in immune function tests: a review of the recommendations of Putman et al. (2003).
    Ryle PR
    Fundam Clin Pharmacol; 2005 Jun; 19(3):317-22; discussion 329-30. PubMed ID: 15910654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective.
    Vearrier D; Greenberg MI
    Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory forum opinion piece*: immunotoxicology assessments in nonhuman primates--challenges and opportunities.
    Lebrec HN
    Toxicol Pathol; 2013; 41(3):548-51. PubMed ID: 22886347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity and its application in toxicology.
    Luster MI; Dean JH; Boorman GA
    Environ Health Perspect; 1982 Feb; 43():31-6. PubMed ID: 7037387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunotoxicity evaluation by immune function tests: focus on the T-dependent antibody response (TDAR) [Overview of a Workshop Session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5-9, 2006 San Diego, CA].
    Herzyk DJ; Holsapple M
    J Immunotoxicol; 2007 Apr; 4(2):143-7. PubMed ID: 18958722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro testing for direct immunotoxicity: state of the art.
    Lankveld DP; Van Loveren H; Baken KA; Vandebriel RJ
    Methods Mol Biol; 2010; 598():401-23. PubMed ID: 19967527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotoxicity screening of drugs and chemicals: value of contact hypersensitivity to picryl chloride in the mouse.
    Descotes J; Tedone R; Evreux JC
    Methods Find Exp Clin Pharmacol; 1985 Jun; 7(6):303-5. PubMed ID: 4058100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding mechanisms of toxicity: insights from drug discovery research.
    Houck KA; Kavlock RJ
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):163-78. PubMed ID: 18063003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical aspects of including functional endpoints in developmental toxicity studies. Case study: immune function in HuCD4 transgenic mice exposed to anti-CD4 MAb in utero.
    Herzyk DJ; Bugelski PJ; Hart TK; Wier PJ
    Hum Exp Toxicol; 2002; 21(9-10):507-12. PubMed ID: 12458908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stem cell models for drug discovery and toxicology studies.
    Liu W; Deng Y; Liu Y; Gong W; Deng W
    J Biochem Mol Toxicol; 2013 Jan; 27(1):17-27. PubMed ID: 23293059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The NIEHS Predictive-Toxicology Evaluation Project.
    Bristol DW; Wachsman JT; Greenwell A
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):1001-10. PubMed ID: 8933048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of immunotoxicity in female Fischer 344/N and Sprague Dawley rats and female B
    Shipkowski KA; Sheth CM; Smith MJ; Hooth MJ; White KL; Germolec DR
    J Immunotoxicol; 2017 Dec; 14(1):215-227. PubMed ID: 29141474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo assessment of immunotoxicity.
    Munson AE; Sanders VM; Douglas KA; Sain LE; Kauffmann BM; White KL
    Environ Health Perspect; 1982 Feb; 43():41-52. PubMed ID: 7060547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systems Toxicology: The Future of Risk Assessment.
    Sauer JM; Hartung T; Leist M; Knudsen TB; Hoeng J; Hayes AW
    Int J Toxicol; 2015; 34(4):346-8. PubMed ID: 25804424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP toxicity report of reproductive dose range-finding study of Genistein (CAS No. 446-72-0) administered in feed to Sprague-Dawley rats.
    Delclos KB; Newbold R
    Toxic Rep Ser; 2007 Nov; (79):1-C2. PubMed ID: 18685712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Future of toxicology--mechanisms of toxicity and drug safety: where do we go from here?
    Stevens JL
    Chem Res Toxicol; 2006 Nov; 19(11):1393-401. PubMed ID: 17112225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Present and future of in vitro immunotoxicology in drug development.
    Galbiati V; Mitjans M; Corsini E
    J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.